Monthly Archives: April 2014

Startup Tech Incubator Announces Biotech Experiments
April 28, 2014

Last week Y Combinator, the well-known and very successful technology startup incubator, announced that it was going to begin experimenting with biotech startups.  This announcement came as a surprise to many.  Several good posts on the subject appeared after a

6 Comments

Building Great Startup Teams In Biotech: A Three Hour Tour
April 18, 2014

Great teams build great companies, and biotech startups are no exception.   I’ve collected a few observations on great teams while collaborating at Atlas on more than half a dozen startups that have made it past the high-risk seed stage

2 Comments

Pushing Forward With Collaborative R&D Models In Biotech: Roche-Spero And Biogen-Ataxion
April 9, 2014

With today’s announcement of Roche’s deal with Spero Therapeutics LLC (here), and last month’s news regarding Biogen’s deal with Ataxion (here), we’ve added further momentum to our strategy of working closely with larger BioPharma partners to create innovative “external R&D”

Leave a comment

Running A Biotech Startup Prussian Style
April 8, 2014

Doing more with less, hanging on to fight the next fight, putting out fires on multiple fronts are all de rigueur here at the Atlas Venture NewCo factory (aptly coined by brother-in-arms, @michael_gilman).  Our seed model (here, here) focuses on

2 Comments

Tradeoffs and Timing: IPO vs. M&A Decision Making in Biotech
April 2, 2014

In light of the continued interest in biotech IPOs by the capital markets, there’s probably not a venture-backed biotech boardroom that hasn’t been discussing the merits of going public. Whether warranted or not, taking a company public via an IPO

1 Comment